Future efforts to elucidate the mechanisms governing the MP60-RBM10 interaction and its downstream effects on HCC pathogenesis could pave the way for innovative therapeutic strategies targeting this pathway. The gene discussed is LINC01138; the disease is hepatocellular carcinoma.